Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Med LifeLTS:0RO5 75 ROC (Joel Greenblatt) % is 9.60% as of Mar. 2026, which is 9% above its 10-year median of 8.83. GuruFocus rates LTS:0RO5 with a GF Score™ of 75/100 and a GF Value™ of lei1.40 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 670 Healthcare Providers & Services companies, Med Life ranks worse than 62.99% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Med Life's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 9.60%.
The historical rank and industry rank for Med Life's ROC (Joel Greenblatt) % or its related term are showing as below:
LTS:0RO5'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 4.71 Med: 8.83 Max: 22.03
Current: 4.71
During the past 11 years, Med Life's highest ROC (Joel Greenblatt) % was 22.03%. The lowest was 4.71%. And the median was 8.83%.
LTS:0RO5's ROC (Joel Greenblatt) % is ranked worse than 62.99% of 670
companies
in the Healthcare Providers & Services industry
Industry Median: 12.43
vs LTS:0RO5: 4.71
Med Life's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -7.90% per year.
Med Life (LTS:0RO5) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
The historical data trend for Med Life's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0RO5 vs HCA, THC, DVA: ROC (Joel Greenblatt) % Comparison
For the Medical Care Facilities subindustry, Med Life's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Med Life ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Med Life's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Med Life's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 9.60% mean?
Med Life (LTS:0RO5) has a ROC (Joel Greenblatt) % of 9.60% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Med Life and its competitors. This is near median its historical median of 8.83. Over the past decade, Med Life's ROC (Joel Greenblatt) % has ranged from 4.71 to 22.03. According to the industry distribution chart, Med Life ranks #422 out of 670 companies in the Healthcare Providers & Services industry, placing it in the top 63%.
Is Med Life's ROC (Joel Greenblatt) % too high?
Med Life's current ROC (Joel Greenblatt) % of 9.60% is near median its 10-year median of 8.83. Over the past 10 years, this metric has ranged from a low of 4.71 to a high of 22.03. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.43. Med Life's value of 9.60% is 22.8% below this industry median. Based on the distribution chart, Med Life ranks #422 out of 670 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Med Life has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Med Life's ROC (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Med Life ranks #422 out of 670 companies for ROC (Joel Greenblatt) %. This places Med Life in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 12.43. Med Life's value of 9.60% is 22.8% below this benchmark. Historically, Med Life's own ROC (Joel Greenblatt) % has ranged from 4.71 to 22.03 over the past decade. While the company's 10-year median is 8.83 vs. the industry median of 12.43, Med Life has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.43, based on 670 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Med Life's current ROC (Joel Greenblatt) % of 9.60% is 22.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Med Life and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Med Life's current ROC (Joel Greenblatt) % is 9.60%, which is near median its own 10-year median of 8.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Med Life stock overvalued right now?
Based on GuruFocus' analysis, Med Life (LTS:0RO5) is currently considered Significantly Overvalued. The stock's GF Value™ is lei1.40, compared to a current price of lei11.38 — trading 712.5% above its estimated fair value. The current ROC (Joel Greenblatt) % is 9.60%, which is near median its 10-year median of 8.83 and 22.8% below the Healthcare Providers & Services industry median of 12.43. Med Life's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Med Life (LTS:0RO5), the current ROC (Joel Greenblatt) % is 9.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Med Life (LTS:0RO5) Overvalued in 2026?
Based on GuruFocus' analysis, Med Life stock appears to be overvalued.
The current stock price of lei11.38 is trading 712.5% above its estimated GF Value™ of lei1.40.
GuruFocus considers Med Life to be Significantly Overvalued.
Key valuation signals for LTS:0RO5:
ROC (Joel Greenblatt) %: 9.60% (near median its 10-year median of 8.83)
GF Value™: lei1.40 vs. price of lei11.38 (712.5% above fair value)
Industry Position: 22.8% below the Healthcare Providers & Services median (#422 of 670)
No single metric tells the full story. See the LTS:0RO5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
75GF Score
Get the complete analysis for LTS:0RO5
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RO5 has been successfully added to your 
